Estimates of effects, ranking, and certainty of evidence for different treatment options vs placebo
Everolimus + SSA (1 RCT; 39 participants)
Estimates of effects, ranking, and certainty of evidence for… may leads to lower everolimus + SSA (3 RCTs; 739 participants) compared with placebo (low certainty).
1 finding from 1 review
- Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta‐analysis 2021 · Cochrane Headline outcomes onlyHR 0.38 [0.26, 0.57]3 studies · 739 participantsLow